If you are an academic working in the areas of biotechnology or pharmaceutical development, this brief text, written by a lawyer and an accomplished researcher, can be a good quick introduction to some of the ramifications of entering into a consulting or advising (or both) agreement with industry
Paul H. King, PhD, PE is a founding member and past Chairman of the Biomedical Engineering department at Vanderbilt University, where he is currently a Professor Emeritus. He has additionally worked in the areas of Nuclear Medicine, Cardiology, Orthopedics, forensics, and Anesthesiology. His teaching specialty was design, he continues this effort, forensics, and some medical device development work. Much of his teaching and research information can be found online.